Morgen Eric bought BIOA
February 17, 2026 · Form 4 insider transaction
Morgen Eric bought 12,500 shares of BioAge Labs, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
12,500
Price
$0.00
Total value
N/A
InsiderMorgen Eric
RoleOfficer, Director
CompanyBioAge Labs, Inc. (BIOA)
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateFebruary 17, 2026
Filing dateFebruary 19, 2026
Shares owned after12,500
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
The option vested or vests as to 1/48th of the total award monthly, with the first tranche vested on February 1, 2026, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the holder's continued service to the Issuer on each vesting date.; Represents an employee stock option directly held by the reporting person's spouse.